Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China
· Delayed Price · Currency is CNY
20.91
-0.23 (-1.09%)
Nov 13, 2024, 3:00 PM CST
Shanghai Pharmaceuticals Holding Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 4,025 | 3,768 | 5,617 | 5,093 | 4,496 | 4,081 | Upgrade
|
Depreciation & Amortization | 2,028 | 2,028 | 2,222 | 2,140 | 2,138 | 1,885 | Upgrade
|
Other Amortization | 351.28 | 351.28 | 195.59 | 186.89 | 160.66 | 134.85 | Upgrade
|
Loss (Gain) From Sale of Assets | -92.48 | -92.48 | -1,439 | -58.29 | -52.15 | -71.34 | Upgrade
|
Asset Writedown & Restructuring Costs | 70.65 | 70.65 | 322.39 | 88.98 | 502.04 | 801.09 | Upgrade
|
Loss (Gain) From Sale of Investments | 105.5 | 105.5 | 30.06 | 204.41 | -126.5 | -779.37 | Upgrade
|
Provision & Write-off of Bad Debts | 254.34 | 254.34 | 276.33 | -54.29 | -84.83 | 159.29 | Upgrade
|
Other Operating Activities | 3,313 | 3,090 | 2,196 | 860.27 | 1,824 | 2,381 | Upgrade
|
Change in Accounts Receivable | -6,432 | -6,432 | -10,081 | -6,156 | -4,072 | -5,084 | Upgrade
|
Change in Inventory | -2,304 | -2,304 | -7,112 | -3,201 | 932.6 | 63.14 | Upgrade
|
Change in Accounts Payable | 4,586 | 4,586 | 12,645 | 5,793 | 1,360 | 2,667 | Upgrade
|
Operating Cash Flow | 5,712 | 5,232 | 4,743 | 5,061 | 6,845 | 6,022 | Upgrade
|
Operating Cash Flow Growth | -20.72% | 10.29% | -6.28% | -26.06% | 13.65% | 92.09% | Upgrade
|
Capital Expenditures | -2,521 | -2,971 | -2,685 | -4,119 | -3,010 | -2,753 | Upgrade
|
Sale of Property, Plant & Equipment | 191.2 | 179.15 | 160.34 | 190.9 | 383.86 | 141.9 | Upgrade
|
Cash Acquisitions | -294.02 | -357.08 | -84.33 | -1,153 | 56.2 | -759.59 | Upgrade
|
Divestitures | 12.86 | 0.5 | 106.8 | -1,454 | 110.13 | 65.9 | Upgrade
|
Investment in Securities | 2,959 | -436.23 | -10,486 | -86.68 | -808.25 | -2,522 | Upgrade
|
Other Investing Activities | 517.94 | 1,092 | 514.75 | 606.31 | 1,562 | 1,243 | Upgrade
|
Investing Cash Flow | 865.66 | -2,492 | -12,473 | -6,016 | -1,706 | -4,584 | Upgrade
|
Short-Term Debt Issued | - | 163.6 | 363.04 | 29.26 | 174.66 | 205.11 | Upgrade
|
Long-Term Debt Issued | - | 79,193 | 63,644 | 56,547 | 49,265 | 40,047 | Upgrade
|
Total Debt Issued | 75,047 | 79,357 | 64,008 | 56,576 | 49,440 | 40,252 | Upgrade
|
Short-Term Debt Repaid | - | -1,325 | -394.85 | -329.58 | -267.97 | -355.14 | Upgrade
|
Long-Term Debt Repaid | - | -73,120 | -60,557 | -53,003 | -48,306 | -38,966 | Upgrade
|
Total Debt Repaid | -74,486 | -74,445 | -60,952 | -53,333 | -48,574 | -39,321 | Upgrade
|
Net Debt Issued (Repaid) | 560.59 | 4,912 | 3,055 | 3,243 | 865.24 | 930.67 | Upgrade
|
Issuance of Common Stock | 18.32 | 106.42 | 13,982 | - | - | - | Upgrade
|
Common Dividends Paid | -3,455 | -3,981 | -3,094 | -2,676 | -2,418 | -2,584 | Upgrade
|
Other Financing Activities | 449.12 | -805.36 | -1,805 | 998.55 | 291.92 | -672.31 | Upgrade
|
Financing Cash Flow | -2,427 | 231.85 | 12,139 | 1,566 | -1,261 | -2,326 | Upgrade
|
Foreign Exchange Rate Adjustments | 32.39 | -5.58 | -12.44 | -50.32 | -17.63 | -1.61 | Upgrade
|
Net Cash Flow | 4,183 | 2,966 | 4,396 | 561.06 | 3,860 | -889.3 | Upgrade
|
Free Cash Flow | 3,191 | 2,261 | 2,058 | 942.55 | 3,835 | 3,269 | Upgrade
|
Free Cash Flow Growth | -23.84% | 9.83% | 118.40% | -75.42% | 17.30% | 174.25% | Upgrade
|
Free Cash Flow Margin | 1.17% | 0.87% | 0.89% | 0.44% | 2.00% | 1.75% | Upgrade
|
Free Cash Flow Per Share | 0.86 | 0.61 | 0.59 | 0.33 | 1.35 | 1.15 | Upgrade
|
Cash Income Tax Paid | 7,059 | 7,384 | 7,599 | 6,239 | 5,849 | 5,622 | Upgrade
|
Levered Free Cash Flow | 898.58 | -1,521 | -595.85 | -1,374 | 1,482 | 664.12 | Upgrade
|
Unlevered Free Cash Flow | 2,030 | -343.35 | 459.95 | -425.52 | 2,365 | 1,542 | Upgrade
|
Change in Net Working Capital | 3,092 | 5,120 | 4,397 | 3,331 | 1,510 | 2,178 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.